Background: Polycystic ovary syndrome (PCOS) is a common endocrine disorder in women of reproductive age with primary manifestations of infertility, menstrual dysfunction and clinical or biochemical hyperandrogenism (hirsutism, acne and elevated androgen). Adiponectin is the most abundant adipokine. It has insulin-sensitizing, anti-atherogenic, and antiinflammatory actions.
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Introduction:
Polycystic ovary syndrome (PCOS) is a common endocrine disorder in women of reproductive age with primary manifestations of infertility, menstrual dysfunction and clinical or biochemical hyperandrogenism (hirsutism, acne and elevated androgen) (1) . Polycystic ovary syndrome affects about 7 to 8% of women and may be the most common cause of anovulation, early pregnancy loss, and later pregnancy complications. All have been implicated in the low fecundity of women with this disorder (2) . Insulin resistance (IR) has been considered to be the most important aetiological aspect of the reproductive and metabolic abnormalities in PCOS (3, 4) . Adipose tissue is an active endocrine organ, by releasing a variety of bioactive peptides and adipokines, modulate body's metabolism at local and systemic levels (5). The production of adipokines has been shown to affect insulin sensitivity and to be an important predictor of the metabolic syndrome (6).
Adiponectin is the most abundant adipokines and is mainly secreted from visceral fat cells (7) . Adiponectin is a protein of 247 amino acids consisting of four domains, with a molecular weight of 30 kDa, and it has insulinsensitizing (8, 9) , anti-atherogenic (10), and anti-inflammatory actions (11) . Also adiponectin modulates a number of metabolic processes, including glucose regulation and fatty acid oxidation (12) . In vitro and in vivo studies have shown that adiponectin has beneficial effects on the reproductive processes and an important relationship with the gonadotropins and other hormones (13) (14) (15) .
Subjects and Methods:
Fifty two (52) women were included in this study with age range (21-34 years). Women were attended to obstetric and gynecology outpatient clinic in Baghdad Teaching Hospital during the period from December 2014 to January 2015. Subjects were divided into two groups: group A: twenty (27) women with PCOS and group B: twenty five (25) women without PCOS (serve as controls). PCOS can be diagnosed when two of the three following criteria are present (oligoovulation and/or anovulation, clinical
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Rana A. Hamdi Polycystic Ovary Syndrome and/or biochemical hyperandrogenism and polycystic ovaries as defined by ultrasonography). PCOS can be diagnosed after the exclusion of other medical conditions and if she fulfilled 2 out of 3 criteria mentioned above. Exclusion criteria included hyperprolactinemia, diabetes mellitus, impaired thyroid, renal or hepatic function and subjects treated with drugs known to influence insulin sensitivity (e.g., steroids, oral contraceptives, metformin, or thiazide diuretics). Serum investigations included fasting blood glucose which was measured by spectrophotometer, testosterone was measured by minividas, fasting serum insulin was measured by enzyme linked immuno sorbent assay (ELISA), Adiponectin measured by ELISA using kit manufactured by (MBL International Corporation), and homeostasis model assessment of insulin resistance (HOMA-IR) calculates the IR by dividing the product of fasting blood glucose level (mg/dl) and serum insulin level (μU/ml) by a constant, i.e. 405. A HOMA-IR value of 2.5 or above were considered as insulin resistant (16 (17) .
Statistical analysis:
Data were analyzed using computer facility of SPSS-17 (Statistical Package for Social Science -version 17). The results were expressed as numbers, range and mean ± SD (standard deviation). Significance of difference was assessed using Student-t test for two independent means.
Results:
Patients and controls were matching for age and body mass index (BMI), there were no significant difference in serum glucose levels between patients and controls but there were significant increase in serum total testosterone levels, serum insulin levels, HOMA in patients comparing to controls. In addition serum adiponectin levels were significantly decreased in patients compared to that of controls (Ta ble 1). Table ( 2) shows the quartile of serum adiponectin levels for patients and controls. This type of statistic give idea about upper (Q3) and lower (Q1) limit of serum adiponectin levels, % of Q1,Q3 and between Q1-Q3 with number of patients and controls in each group. 
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Discussion:
PCOS is an important metabolic and reproductive disorder and is likely multifactorial in origin. Insulin resistance is important in the pathogenesis of PCOSʺ (18) . The "central paradox" in PCOS is that the ovary remains sensitive to insulin-induced androgen production de spite a systemic insulin-resistant state. The serine phosphorylation theory may explain this paradox. Ser ine phosphorylation of the insulin receptor inhibits tyrosine kinase activity of the receptor, and this defect in insulinsignaling causes insulin resistance in women with PCOS (19) . Serine phosphorylation of the main regulatory enzyme of androgen biosynthesis, P450c17, may modulate 17, 20 lyase activity and induce androgen production. This hypothesis suggests that a single kinase might phosphorylate the insulin recep tor and P450c17 to produce hyperandrogenemia and hyperinsulinemia in women with PCOS (20) . Adipose tissue in women with PCOS is character ized by hypertrophic adipocytes and impaired lipoly sis and insulin action. The expression and secretion of a wide variety of adipokines implicated in insulin re sistance, including adiponectin is also altered in women with PCOS (21) . Adiponectin exerts insulinsensitizing properties by stimulating fatty acid oxidation and suppressing he patic gluconeogenesis, and a dysregulation of adipo nectin has been implicated in the pathogenesis of in sulin resistance (22) . Our findings showed that serum adiponectin levels were significantly lower in women with PCOS as compared with those BMI-matched controls. This result agrees with previous study which found that adiponectin levels in nonobese women with PCOS were significantly lower than those in BMI-matched controls (18) . Further study support these results (23) which suggest that decrease adiponectin levels in women with PCOS might be a result of increasing IR in these patients. Furthermore, family history of PCOS and IR were also significantly associated with lower adiponectin levels. ʺIncreasing evidence suggests that genetic factors play an important role in the pathogenesis of PCOS. Interestingly, prevalence of PCOS in South East Asians settled in United Kingdom was 52%, which is an 18% higher rate than the native population, suggestive of some genetic predisposition of PCOS among certain races (24) . In addition to familial clustering of PCOS in first degree relatives (25) , it has been shown that the pre-pubertal daughters with normal BMI, of women with PCOS, manifest with disturbed metabolic profile including hypoadiponectenemia and hyperinsulinemia compared to daughters of healthy women (26), although family history is an important risk factor, environmental triggers are also playing a role, e.g. diet, and exercise. In addition, dysfunctional changes in the metabolism of carbohydrates, insulin action, and steroid hormones have also been implicated ʺ (23) . A systematic review and meta-analysis by Toulis et al., on a sub-analysis by using studies only with PCOS cases and controls matched on BMI, revealed that PCOS women had lower levels of adiponectin after controlling for the potential effects of obesity by BMI matching. This suggests that serum adiponectin levels are not independently determined by the degree of adiposity in women but underlying disease may also have some role. A possible explanation for this finding is that lower adiponectin levels in PCOS women might be a result of increasing IR in these patients (27) . ʺIR might possibly be a link between lower adiponectin level and development of polycystic ovarian syndrome; however, whether low adiponectin is a cause or a consequence of IR in PCOS remains debatedʺ (23) .
Conclusions:
Serum adiponectin levels are not independently determined by the degree of obesity in women but underlying disease may also have some role and this may due to insulin resistance in these patients thus determining serum adiponectin may serve as a useful marker in detecting cases of normal weight women with PCOS.
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